Hemithoracic Arc Radiotherapy Post Pleural Decortication
NCT06910449
Summary
Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication
Eligibility
Inclusion Criteria: * Evidence of metastatic disease. * Underwent Pleural decortication. * Able to provide informed consent. Exclusion Criteria: * Poor pulmonary function tests. * Recurrent or palliative cases. * Inability to attend full course of Radiotherapy or follow up visits.
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06910449